In vivo synaptic activity-independent co-uptakes of amyloid β1-42 and Zn2+ into dentate granule cells in the normal brain

Sci Rep. 2019 Apr 24;9(1):6498. doi: 10.1038/s41598-019-43012-0.

Abstract

Neuronal amyloid β1-42 (Aβ1-42) accumulation is considered an upstream event in Alzheimer's disease pathogenesis. Here we report the mechanism on synaptic activity-independent Aβ1-42 uptake in vivo. When Aβ1-42 uptake was compared in hippocampal slices after incubating with Aβ1-42, In vitro Aβ1-42 uptake was preferentially high in the dentate granule cell layer in the hippocampus. Because the rapid uptake of Aβ1-42 with extracellular Zn2+ is essential for Aβ1-42-induced cognitive decline in vivo, the uptake mechanism was tested in dentate granule cells in association with synaptic activity. In vivo rapid uptake of Aβ1-42 was not modified in the dentate granule cell layer after co-injection of Aβ1-42 and tetrodotoxin, a Na+ channel blocker, into the dentate gyrus. Both the rapid uptake of Aβ1-42 and Zn2+ into the dentate granule cell layer was not modified after co-injection of CNQX, an AMPA receptor antagonist, which blocks extracellular Zn2+ influx, Both the rapid uptake of Aβ1-42 and Zn2+ into the dentate granule cell layer was not also modified after either co-injection of chlorpromazine or genistein, an endocytic repressor. The present study suggests that Aβ1-42 and Zn2+ are synaptic activity-independently co-taken up into dentate granule cells in the normal brain and the co-uptake is preferential in dentate granule cells in the hippocampus. We propose a hypothesis that Zn-Aβ1-42 oligomers formed in the extracellular compartment are directly incorporated into neuronal plasma membranes and form Zn2+-permeable ion channels.

MeSH terms

  • 6-Cyano-7-nitroquinoxaline-2,3-dione / administration & dosage
  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Amyloid beta-Peptides / metabolism*
  • Amyloid beta-Peptides / pharmacokinetics
  • Animals
  • Biological Transport / drug effects
  • Brain / metabolism*
  • Dentate Gyrus / metabolism*
  • Excitatory Amino Acid Antagonists / administration & dosage
  • Excitatory Amino Acid Antagonists / pharmacology
  • Hippocampus / metabolism
  • Male
  • Microscopy, Confocal
  • Peptide Fragments / metabolism*
  • Peptide Fragments / pharmacokinetics
  • Rats, Wistar
  • Sodium Channel Blockers / administration & dosage
  • Sodium Channel Blockers / pharmacology
  • Synapses / metabolism*
  • Tetrodotoxin / administration & dosage
  • Tetrodotoxin / pharmacology
  • Zinc / metabolism*
  • Zinc / pharmacokinetics

Substances

  • Amyloid beta-Peptides
  • Excitatory Amino Acid Antagonists
  • Peptide Fragments
  • Sodium Channel Blockers
  • amyloid beta-protein (1-42)
  • Tetrodotoxin
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • Zinc